Drug Database
Back to search

United States· US:61703-363_4edbffab-0628-4c35-ac6a-76a629f3c9dd

Oxaliplatin

A oxaliplatin product containing oxaliplatin, registered in United States by Hospira, Inc.. The same ATC class is registered in 17 of our 19 countries.

ATC L01XA03

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedOxaliplatinATCL01XA03REGISTER NO.US:61703-363_4edbffab…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about oxaliplatinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Oxaliplatin is registered in 17 of 19 countries.

Countries holding a registration under ATC L01XA03 (oxaliplatin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose
Search oxaliplatin products by name

Oxaliplatin · ATC L01XA03

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of oxaliplatin costs, country by country.

Normalised to the WHO defined daily dose (11 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Oxaliplatin · price per daily dose (11 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$24.21
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
OXALIPLATIN
Manufacturer
Hospira, Inc.
Country
United States (US)
ATC code
L01XA03
ATC class
Oxaliplatin
Defined daily dose
11 mg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    61703-363-18
  • ndc11
    61703-363-22

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

740 interactions on record for oxaliplatin.

Graded by severity as the source publishes them — 101 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check oxaliplatin against other medicinesHow interaction checks work

Oxaliplatin · interactions on record

740 records

  • 101 severe
  • 453 moderate
  • 1 minor
  • 185 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxaliplatin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxaliplatin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Ebeoxal, Oxaliplatin Accord
  • Belgium · Eloxatin, Oxaliplatin Accord Healthcare
  • Bulgaria · Оксалиплатин Акорд, Оксалиплатин Булгермед
  • Cyprus · Oxaliplatin
  • Czechia · Oxaliplatin Accord, Oxaliplatin Agmed
  • Germany · Eloxatin, Medoxa
  • Denmark · Oxaliplatin Accord, Oxaliplatin Actavis
  • Estonia · Oxaliplatin Accord, Oxaliplatin Kabi
  • Spain · Oxaliplatino Accord, Oxaliplatino Aurovit
  • Finland · Oxaliplatin Accord
  • France · Dacplat, Eloxatine
  • United Kingdom (Northern Ireland) · Oxaliplatin Accord Healthcare, Oxaliplatin Amarox
  • Greece · Elatofen, Oxaliplatin Deltapharma
  • Croatia · Oksaliplatin Kalceks, Oxaliplatin Kabi
  • Hungary · Oxaliplatin Accord, Oxaliplatin Kabi
  • Ireland · Oxaliplatin Accord Healthcare Ireland, Oxaliplatin Fresenius Kabi Deutschland
  • Iceland · Oxaliplatin Actrevo, Oxaliplatin Teva
  • Italy · Oxaliplatino Accord, Oxaliplatino Aurobindo
  • Lithuania · Oxaliplatin Accord, Oxaliplatin Kabi
  • Luxembourg · Eloxatin, Oxaliplatine Fresenius Kabi
  • Latvia · Oxaliplatin Accord, Oxaliplatin Kabi
  • Malta · Oxaviatin
  • Netherlands · Oxaliplatin Hikma, Oxaliplatine Accord
  • Norway · Oksaliplatin Sun, Oxaliplatin Fresenius Kabi
  • Poland · Oxaliplatin Ebewe, Oxaliplatin Eugia
  • Portugal · Oxaliplatina Accord, Oxaliplatina Aurovitas
  • Romania · Oxaliplatin Accord, Oxaliplatin Aqvida Gmbh
  • Sweden · Oxaliplatin Accord, Oxaliplatin Eugia
  • Slovenia · Oksaliplatin Kabi, Oksaliplatin Sandoz
  • Slovakia · Oxaliplatin Agmed, Oxaliplatin Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d54448b2-ee46-41b9-8041-00c7491d365e
GET /v1/drugs/d54448b2-ee46-41b9-8041-00c7491d365e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "5",
  "substance": "OXALIPLATIN",
  "productndc": "61703-363",
  "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA078813",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about oxaliplatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console